Hematology/Oncology

Top Story

VIDEO: Ibrutinib yields superior PFS vs. standard care in chronic lymphocytic leukemia

December 13, 2018

SAN DIEGO — In this video, Ryan W. Jacobs, MD, head of the clinical trials program for chronic lymphocytic leukemia at the Levine Cancer Institute, reviews phase 3 data from the ALLIANCE trial, which showed ibrutinib alone or in combination with rituximab prolonged PFS compared with bendamustine plus rituximab among treatment-naive patients with chronic lymphocytic leukemia.

Meeting News

Allogeneic stem cell transplant induces long-term responses in follicular lymphoma

December 13, 2018

Nonmyeloablative allogeneic stem cell transplant results in complete responses that last for up to a decade among patients with relapsed follicular lymphoma, including…

Meeting News

Combination treatment with rituximab demonstrates ‘excellent’ results as induction therapy

December 13, 2018

Induction therapy with rituximab and bendamustine followed by rituximab plus high-dose cytarabine and then an autologous stem cell transplant increased durable…

Meeting NewsPerspective

Gut microbial diversity before stem cell transplantation may impact survival

December 13, 2018

SAN DIEGO — Higher gut microbial diversity was associated with improved survival in a multinational cohort of patients undergoing hematopoietic stem cell…

Clinical Trials Snapshot

Use of Ligand-Inducible Autologous T-cells Engineered to Target PSCA on Tumor Cells in Selected Advanced Solid Tumors

Cell Therapy Next, December 2018

Phase 1/2 study looking to evaluate the safety and activity of BPX-601 in previously treated advanced solid tumors (gastric, pancreatic or prostate) expressing high…

More Headlines »

CME CNE CPE